Zobrazeno 1 - 10
of 35
pro vyhledávání: '"N. N. Senzer"'
Autor:
N. N. Senzer, J. S. Simon, Natalie C. Twine, Tadashi Kadowaki, David S. Hong, James P. O'Brien, R. Kurzrock, A. Eisen, Min Ren, John Nemunaitis, Yasuhiro Funahashi
Publikováno v:
Journal of Clinical Oncology. 29:8595-8595
8595 Background: E7080 is an oral TKI targeting VEGFR1-3, FGFR1-4, PDGFRβ, RET and KIT, which affects tumor cell proliferation and tumor vascularization in laboratory models. Tumor response (RECIST...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47c1df906ee8ef6a28d7aa8dc35f981b
https://doi.org/10.1200/jco.2011.29.15_suppl.8595
https://doi.org/10.1200/jco.2011.29.15_suppl.8595
Autor:
E. G. Chiorean, N. N. Senzer, M. J. Borad, J. R. Infante, Julian R. Molina, R. W. Weber, V. K. Langmuir, Glen J. Weiss, H. Lee, Svetomir N. Markovic
Publikováno v:
Journal of Clinical Oncology. 28:e19009-e19009
e19009 Background: TH-302 is a 2-nitroimidazole prodrug of the DNA alkylator, bromo-isophosphoramide mustard. Following the phase I establishment of monotherapy weekly maximum tolerated dose (MTD) ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3128a74c7dc10a527290f90fa26f01b
https://doi.org/10.1200/jco.2010.28.15_suppl.e19009
https://doi.org/10.1200/jco.2010.28.15_suppl.e19009
Autor:
Aung Naing, Jennifer Mink, N. N. Senzer, David S. Hong, Jennifer J. Wheler, B. S. Koetz, John Nemunaitis, R. Kurzrock, W. Hanekom, Min Ren
Publikováno v:
Journal of Clinical Oncology. 28:2540-2540
2540 Background: E7080 is a potent, orally administered, receptor tyrosine kinase inhibitor of KDR, VEGFR1, VEGFR3, FGFR2, and RET. Antiangiogenic and antiproliferative activity were seen in human ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::daac9b1c83fc42dd0c6ae4a2d3fa4910
https://doi.org/10.1200/jco.2010.28.15_suppl.2540
https://doi.org/10.1200/jco.2010.28.15_suppl.2540
Autor:
S. Leong, H. Safran, P. J. Loehrer, Hagop Youssoufian, N. J. Zojwalla, L. B. Anthony, N. N. Senzer, M. H. Shah
Publikováno v:
Journal of Clinical Oncology. 28:TPS220-TPS220
TPS220 Background: The somatostatin analogue octreotide is an established therapy offering symptom relief in patients with neuroendocrine tumors; however, their prognosis remains limited. Cixutumum...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b02c10f1a746070a216b7f900f6c231d
https://doi.org/10.1200/jco.2010.28.15_suppl.tps220
https://doi.org/10.1200/jco.2010.28.15_suppl.tps220
Publikováno v:
Journal of Clinical Oncology. 26:7584-7584
7584 Background: HSPPC-96 (Oncophage; also vitespen) is a novel, autologous, tumor-derived heat shock protein (gp96)-peptide complex vaccine that has shown signals of clinical activity in patients ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::321b9eedaaf51473e7b52099965f1767
https://doi.org/10.1200/jco.2008.26.15_suppl.7584
https://doi.org/10.1200/jco.2008.26.15_suppl.7584
Autor:
N. N. Senzer, H. L. Kaufman, T. Amatruda, M. Nemunaitis, T. R. Reid, C. Love, T. Marshall, H. Goldsweig, R. S. Coffin, J. J. Nemunaitis
Publikováno v:
Journal of Clinical Oncology. 26:9008-9008
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d326a8dbc8f59f0a95f11d5375fc9ac
https://doi.org/10.1200/jco.2008.26.15_suppl.9008
https://doi.org/10.1200/jco.2008.26.15_suppl.9008
Autor:
N. N. Senzer, S. Ashworth, R. Kurzrock, C. S. Ng, David S. Hong, John Nemunaitis, M. Jansen, R. S. Atienza, A. Das, E. A. Zang
Publikováno v:
Journal of Clinical Oncology. 26:14583-14583
14583 Background: E7080, a multikinase inhibitor, has potent inhibitory activity against the split-kinase family of transmembrane growth factor receptors, including VEGFR1–3, PDGFRβ and FGFR1. In s...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c9a6c4eaa476163a30ed53e28e211e5
https://doi.org/10.1200/jco.2008.26.15_suppl.14583
https://doi.org/10.1200/jco.2008.26.15_suppl.14583
Autor:
N N, Senzer
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 165(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bf8d024d0ee63c0ddfcd9d749e4dd1ce
https://pubmed.ncbi.nlm.nih.gov/2683170
https://pubmed.ncbi.nlm.nih.gov/2683170
Publikováno v:
Cancer treatment reports. 62(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b660983ecad6ae766e3d1770faad3c44
https://pubmed.ncbi.nlm.nih.gov/210945
https://pubmed.ncbi.nlm.nih.gov/210945
Autor:
Wu J; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Liu S; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Yu J; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Zhou G; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Rao D; Gradalis, Carrollton, TX, USA., Jay CM; Gradalis, Carrollton, TX, USA., Kumar P; Gradalis, Carrollton, TX, USA., Sanchez R; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Templeton N; Gradalis, Carrollton, TX, USA., Senzer N; 1] Gradalis, Carrollton, TX, USA [2] Mary Crowley Cancer Research Center, Dallas, TX, USA., Maples P; Gradalis, Carrollton, TX, USA., Nemunaitis J; 1] Gradalis, Carrollton, TX, USA [2] Mary Crowley Cancer Research Center, Dallas, TX, USA., Brunicardi FC; Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Publikováno v:
Cancer gene therapy [Cancer Gene Ther] 2014 Feb; Vol. 21 (2), pp. 48-53. Date of Electronic Publication: 2014 Jan 24.